AMANDA GRIMES to Prospective Studies
This is a "connection" page, showing publications AMANDA GRIMES has written about Prospective Studies.
Connection Strength
0.044
-
Eltrombopag for Newly Diagnosed Pediatric Immune Thrombocytopenia Requiring Treatment: The PINES Randomized Clinical Trial. JAMA. 2025 11 25; 334(20):1816-1826.
Score: 0.028
-
Rapid infusion of rituximab is well tolerated in children with hematologic, oncologic, and rheumatologic disorders. Pediatr Blood Cancer. 2018 Jan; 65(1).
Score: 0.016